Alterations of the Intracellular Peptidome in Response to the Proteasome Inhibitor Bortezomib
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alterations of the Intracellular Peptidome in Response to the Proteasome Inhibitor Bortezomib
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 1, Pages e53263
Publisher
Public Library of Science (PLoS)
Online
2013-01-08
DOI
10.1371/journal.pone.0053263
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Peptidomic Analysis of HEK293T Cells: Effect of the Proteasome Inhibitor Epoxomicin on Intracellular Peptides
- (2012) Lloyd D. Fricker et al. JOURNAL OF PROTEOME RESEARCH
- Identification of intracellular peptides in rat adipose tissue: Insights into insulin resistance
- (2012) Denise A. Berti et al. PROTEOMICS
- Natural intracellular peptides can modulate the interactions of mouse brain proteins and thimet oligopeptidase with 14-3-3ε and calmodulin
- (2012) Lilian C. Russo et al. PROTEOMICS
- Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse Events
- (2011) S. Arastu-Kapur et al. CLINICAL CANCER RESEARCH
- Proteasome Inhibitor PS-341 (Bortezomib) Induces Calpain-dependent IκBα Degradation
- (2010) Chunyang Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes
- (2010) Jan H Kessler et al. NATURE IMMUNOLOGY
- Small Peptides Switch the Transcriptional Activity of Shavenbaby During Drosophila Embryogenesis
- (2010) T. Kondo et al. SCIENCE
- Peptidic modulators of protein-protein interactions: Progress and challenges in computational design
- (2009) Mor Rubinstein et al. BIOPOLYMERS
- The Role of ATF4 Stabilization and Autophagy in Resistance of Breast Cancer Cells Treated with Bortezomib
- (2009) M. Milani et al. CANCER RESEARCH
- The proteolytic activity of insulin-degrading enzyme: a mass spectrometry study
- (2009) Giuseppe Grasso et al. JOURNAL OF MASS SPECTROMETRY
- Aminopeptidase inhibition as a targeted treatment strategy in myeloma
- (2009) H. E. Moore et al. MOLECULAR CANCER THERAPEUTICS
- Argyrin A Reveals a Critical Role for the Tumor Suppressor Protein p27kip1 in Mediating Antitumor Activities in Response to Proteasome Inhibition
- (2008) Irina Nickeleit et al. CANCER CELL
- Bortezomib in multiple myeloma
- (2008) Evangelos Terpos et al. Expert Opinion on Drug Metabolism & Toxicology
- Autophagy activation by rapamycin eliminates mouse Mallory-Denk bodies and blocks their proteasome inhibitor-mediated formation
- (2008) Masaru Harada et al. HEPATOLOGY
- Peptidomics ofCpefat/fatmouse brain regions: implications for neuropeptide processing
- (2008) Xin Zhang et al. JOURNAL OF NEUROCHEMISTRY
- Bortezomib induces apoptosis in esophageal squamous cell carcinoma cells through activation of the p38 mitogen-activated protein kinase pathway
- (2008) M. Lioni et al. MOLECULAR CANCER THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started